CorVent Medical, Inc. — Form D/A
CorVent Medical, Inc. of Fargo, ND, a company, filed a Form D amendment with the SEC on 2020-05-13. The offering totals $4.5M, of which $4.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-05-13
- Form: D/A
- Accession: 0001811862-20-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $4.5M
- Amount sold: $4.5M
- Investors: 6
- Date of first sale: 2020-04-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-366807
Issuer
- Name: CorVent Medical, Inc.
- CIK: 0001811862
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 4837 Amber Valley Parkway S, Fargo, ND, 58104
- Phone: 612-670-3871
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Rob Faulkner | Director | New York, NY |
| Mark Gelfand | Director | New York, NY |
| Lukas Geunther | Director | New York, NY |
| Mark Gelfand | Executive Officer | New York, NY |
| Richard S Walsh | Director | Fargo, ND |
| Richard S Walsh | Executive Officer | Fargo, ND |
| Jeremy S Nelson | Executive Officer | Fargo, ND |
| John S O'Connor | Director | Fargo, ND |
| Mark S Gelfand | Director | Fargo, ND |
| Travis S Murphy | Executive Officer | Fargo, ND |
| John S O'Mahony | Executive Officer | Fargo, ND |
| Randy S Schneider | Director | Fargo, ND |
| Mark S Tibbles | Director | Fargo, ND |
| Murphy S Travis | Executive Officer | Fargo, ND |
| John S Ballantyne | Director | Fargo, ND |
| John A Ballantyne | Director | Toronto, A6 |
Other filings by this issuer (4)
More